Skip to main content
Premium Trial:

Request an Annual Quote

UK's BBSRC Earmarks Cash for Bioinformatics Resources, Systems Bio Tools

NEW YORK (GenomeWeb News) —The UK’s Biotechnology and Biological Sciences Research Council this week issued two calls for proposals of interest to bioinformatics.
 
The first, “Bioinformatics and Biological Resources Fund,” has set aside £6 million ($11.4 million) for a pilot project “to support the establishment, maintenance, and enhancement of bioinformatic and biological resources required by bioscience communities.”
 
The fund will support “high quality, strategically relevant” resources that are “necessary to underpin the UK's international quality bioscience.” Grants are available for up to five years. BBSRC said it expects to award grants across a range of £50,000 to £1.5 million.
 
The closing date for expressions of interest is Dec. 15. Further information on the initiative is available here.
 
The second proposal, “Research Networks: Mathematical Tools for Systems Biology,” will provide £400,000 over three years to support up to six research networks “that will bring together mathematical scientists and life scientists in order to tackle key challenges in systems biology.”
 
Each network will focus on a different area of the “mathematics/systems biology interface,” BBSRC said.
 
The closing date for proposals is March 7, 2007. Further details are available here.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.